Tradename | Company | Number | Date | Products |
---|---|---|---|---|
GLUCAGON | Fresenius Kabi | N-201849 RX | 2015-05-08 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BAQSIMI | Amphastar Pharmaceuticals | N-210134 RX | 2019-07-24 | 1 products, RLD, RS |
GVOKE PFS | Xeris Pharmaceuticals | N-212097 RX | 2019-09-10 | 1 products, RLD, RS |
GVOKE HYPOPEN | Xeris Pharmaceuticals | N-212097 RX | 2019-09-10 | 2 products, RLD, RS |
GVOKE KIT | Xeris Pharmaceuticals | N-212097 RX | 2021-08-20 | 1 products, RLD, RS |
GVOKE VIALDX | Xeris Pharmaceuticals | N-212097 RX | 2025-03-14 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
baqsimi | New Drug Application | 2024-11-13 |
glucag0n | New Drug Application | 2022-12-09 |
glucagon | New Drug Application | 2025-03-31 |
glucagon glucagon | New Drug Application | 2019-05-22 |
gvoke hypopen gvoke kit gvoke pfs | New Drug Application | 2023-01-10 |
gvoke hypopen gvoke pfs | New Drug Application | 2021-07-15 |
gvoke hypopen gvoke kit gvoke pfs | New Drug Application | 2025-05-27 |
gvoke hypopen gvoke pfs | New Drug Application | 2019-09-10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypoglycemia | D007003 | — | E16.2 | 1 | — | — | — | — | 1 |
Drug common name | Glucagon |
INN | glucagon |
Description | Glucagon is a 29-amino acid peptide hormone consisting of His, Ser, Gln, Gly, Thr, Phe, Thr, Ser, Asp, Tyr, Ser, Lys, Tyr, Leu, Asp, Ser, Arg, Arg, Ala, Gln, Asp, Phe, Val, Gln, Trp, Leu, Met, Asn and Thr residues joined in sequence. |
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O |
PDB | — |
CAS-ID | 9007-92-5 |
RxCUI | — |
ChEMBL ID | CHEMBL266481 |
ChEBI ID | 5391 |
PubChem CID | 16132283 |
DrugBank | DB00040 |
UNII ID | 76LA80IG2G (ChemIDplus, GSRS) |